# Exponent Inc. (EXPO) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Industrials / Construction & Engineering. Price $68.35, market value $3.2 billion.

## Valuation
- **P/E (trailing): 30.7×** (5-yr avg 44.9×, 3-yr avg 39.5×). Exponent Inc. trades at 30.7× trailing earnings, well below its own five-year average of 44.9×: cheap by its own standards. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 24.1×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 5.1×**. Each dollar of revenue is priced at 5.1×.
- **Price / book: 11.3×**. The shares trade at 11.3× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 3.3%** (5-yr avg 2.5%). Free cash flow equals 3.3% of the market value, above its five-year average of 2.5%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 3.3%**. The inverse of the P/E: 3.3% of the price is earned each year.

## Profitability
- **Operating margin: 20.2%**. 20.2% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 18.2%**. 18.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 27.2%**. 27.2% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on assets: 14.4%**. Each dollar of assets produces 14.4% of profit.

## Growth
- **Revenue growth (1 yr): 4.2%** (3-yr 4.3%/yr, 5-yr 7.8%/yr). Revenue grew 4.2% over the last year, against 7.8% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -1.9%** (3-yr 1.8%/yr, 5-yr 6.0%/yr). Earnings per share fell 1.9%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 14.4%/yr**. Free cash flow has compounded at 14.4% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Current ratio: 2.40** (quick 2.40). Current assets cover the next year's liabilities 2.40 times.
- **Altman Z-score: 7.38**. A Z-score of 7.38 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 1.80%** ($1.22 per share, trailing). Exponent Inc. yields 1.80%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 57%** (55% of free cash flow). 57% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 13**. 13 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 9.6%/yr** (1-yr 7.1%). The dividend has grown 9.6% a year over five years.

## Analyst view
- **Analyst consensus: buy** (3 analysts). 3 analysts cover Exponent Inc.; the consensus is buy, with an average price target of $84.00 (+23% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -4.7%** (YTD -0.7%, 3-mo 14.6%). The shares are down 4.7% over twelve months including dividends.
- **From 52-week high: -16.6%** (31.7% above the low). Trading 17% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 50**. An RSI of 50 is neutral.
- **Beta (1 yr): 0.51** (volatility 32%). Beta of 0.51 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=EXPO · Page: https://foliofundamentals.com/stocks/expo

Not investment advice.